Bath & Body Works (NYSE:BBWI) Sets New 1-Year Low – What’s Next?

Bath & Body Works, Inc. (NYSE:BBWI)’s stock price hit a new 52-week low during trading on Tuesday . The company traded as low as $23.43 and last traded at $23.4650, with a volume of 1658024 shares traded. The stock had previously closed at $24.23.

Analyst Ratings Changes

BBWI has been the topic of a number of research reports. Wall Street Zen downgraded shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. JPMorgan Chase & Co. restated a “neutral” rating and set a $26.00 target price on shares of Bath & Body Works in a research report on Monday, October 6th. Citigroup cut their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a research report on Tuesday, August 19th. Telsey Advisory Group restated an “outperform” rating and set a $38.00 target price on shares of Bath & Body Works in a research report on Thursday, August 28th. Finally, Morgan Stanley cut their target price on shares of Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating on the stock in a research report on Friday, September 12th. Eleven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $36.39.

Bath & Body Works Stock Performance

The firm has a market capitalization of $4.88 billion, a price-to-earnings ratio of 7.03, a P/E/G ratio of 0.86 and a beta of 1.52. The business’s 50-day moving average is $26.88 and its two-hundred day moving average is $28.96.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.37. The business had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. Bath & Body Works’s revenue for the quarter was down .8% on a year-over-year basis. During the same period last year, the company posted $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 3.4%. The ex-dividend date was Friday, August 22nd. Bath & Body Works’s dividend payout ratio (DPR) is 23.74%.

Institutional Trading of Bath & Body Works

Several hedge funds have recently bought and sold shares of BBWI. Victory Capital Management Inc. raised its holdings in Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company’s stock worth $206,119,000 after buying an additional 6,752,274 shares during the period. AQR Capital Management LLC grew its stake in shares of Bath & Body Works by 267.8% in the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock valued at $121,073,000 after buying an additional 2,907,506 shares in the last quarter. Fuller & Thaler Asset Management Inc. grew its stake in shares of Bath & Body Works by 115.7% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock valued at $111,581,000 after buying an additional 1,973,679 shares in the last quarter. Norges Bank bought a new position in shares of Bath & Body Works in the second quarter valued at $57,746,000. Finally, Vaughan Nelson Investment Management L.P. acquired a new stake in Bath & Body Works during the 3rd quarter valued at $43,113,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.